921
Views
32
CrossRef citations to date
0
Altmetric
Review

Current treatment strategies in autoimmune hemolytic disorders

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Chattree Hantaweepant, Prat Pairattanakorn, Khemajira Karaketklang, Weerapat Owattanapanich & Yingyong Chinthammitr. (2019) Efficacy and safety of second-line treatment in Thai patients with primary warm-type autoimmune hemolytic anemia. Hematology 24:1, pages 720-726.
Read now
Wilma Barcellini, Bruno Fattizzo & Anna Zaninoni. (2018) Current and emerging treatment options for autoimmune hemolytic anemia. Expert Review of Clinical Immunology 14:10, pages 857-872.
Read now
Wilma Barcellini & Bruno Fattizzo. (2018) Autoimmune hemolytic anemia - progress in emerging treatment options. Expert Opinion on Orphan Drugs 6:4, pages 273-282.
Read now
James W Swann & Barbara J Skelly. (2016) Canine autoimmune hemolytic anemia: management challenges. Veterinary Medicine: Research and Reports 7, pages 101-112.
Read now
Wilma Barcellini. (2016) The clinical dilemma and management of red cell autoantibodies. Expert Review of Hematology 9:4, pages 325-327.
Read now

Articles from other publishers (26)

Maria Celeste Fatone & Lorenzo Cirasino. (2022) Practical therapy for primary autoimmune hemolytic anemia in adults. Clinical and Experimental Medicine 23:3, pages 727-736.
Crossref
Florence Joly, Lisa Anne Schmitt, Patricia Ann McGee Watson, Emilie Pain & Damien Testa. (2022) The Burden of Cold Agglutinin Disease on Patients’ Daily Life: Web-Based Cross-sectional Survey of 50 American Patients. JMIR Formative Research 6:7, pages e34248.
Crossref
Tahir Dalkiran, Mehmet Mercan, Sevcan Ipek, Ufuk Utku Güllü, Yasar Kandur, Can Acipayam & Cengiz Dilber. (2022) Therapeutic Plasma Exchange in Pediatric Patients: Results from a Single Center. Journal of Pediatric Intensive Care.
Crossref
Petra Richter, Hendryk Fischer & René Dörfelt. (2021) Immunoadsorption in a dog with severe immune mediated hemolytic anemia. Journal of Clinical Apheresis 36:4, pages 668-672.
Crossref
Emma Westermann-Clark, Cristina Adelia Meehan, Anna K. Meyer, Joseph F. Dasso, Devendra Amre, Maryssa Ellison, Bhumika Patel, Marisol Betensky, Charles Isaac Hauk, Jennifer Mayer, Jonathan Metts, Jennifer W. Leiding, Panida Sriaroon, Ambuj Kumar, Irmel Ayala & Jolan E. Walter. (2021) Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort. Frontiers in Immunology 12.
Crossref
Machiel van den Akker, David Smolders, Sarah Mahieu, Kimberley Bonouvrie & Jutte van der Werf Ten Bosch. (2020) Primary IgA-mediated Autoimmune Hemolytic Anemia in an Infant Successfully Treated With Rituximab. Journal of Pediatric Hematology/Oncology 42:7, pages e615-e619.
Crossref
Leif Hanitsch, Ulrich Baumann, Kaan Boztug, Ulrike Burkhard‐Meier, Maria Fasshauer, Pirmin Habermehl, Fabian Hauck, Gerd Klock, Johannes Liese, Oliver Meyer, Rainer Müller, Jana Pachlopnik‐Schmid, Dorothea Pfeiffer‐Kascha, Klaus Warnatz, Claudia Wehr, Kirsten Wittke, Tim Niehues & Horst Bernuth. (2020) Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline. European Journal of Immunology 50:10, pages 1432-1446.
Crossref
Veronika M. Dudnyk, Tatyana H. Korol, Hennadii M. Rudenko, Kateryna V. Khromykh & Maryna O. Shalamai. (2020) CONGENITAL HEMOLYTIC ANEMIA IN CHILDREN, FEATURES OF THE COURSE AND DIAGNOSIS. THE CLINICAL CASE. Wiadomości Lekarskie 73:8, pages 1796-1799.
Crossref
Katharina R. Beck, George R. ThompsonIIIIII & Alex Odermatt. (2020) Drug-induced endocrine blood pressure elevation. Pharmacological Research 154, pages 104311.
Crossref
Jill Adamski. 2019. Mayo Clinic Critical and Neurocritical Care Board Review. Mayo Clinic Critical and Neurocritical Care Board Review C56 C56.P33 .
Hana Cho & Navdeep Kumar. (2019) Cold agglutinin disease and its implications for dental treatment. Special Care in Dentistry 39:4, pages 435-440.
Crossref
Renee K McAlister, Mahsa S Talbott & Nishitha M Reddy. (2018) Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab. Journal of Oncology Pharmacy Practice 25:3, pages 706-709.
Crossref
Ulrich JägerShirley D’SaChristian Schörgenhofer, Johann Bartko, Ulla Derhaschnig, Christian SillaberPetra Jilma-StohlawetzMichael FillitzThomas SchenkGary Patou, Sandip Panicker, Graham C. Parry, James C. Gilbert & Bernd Jilma. (2019) Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial. Blood 133:9, pages 893-901.
Crossref
José Carlos Jaime-PérezPatrizia Aguilar-CalderónLorena Salazar-CavazosAndrés Gómez-De LeónDavid Gómez-Almaguer. (2019) Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico. Blood Research 54:2, pages 131.
Crossref
Ilene Weitz. 2019. Anemia in the Young and Old. Anemia in the Young and Old 137 145 .
Wilma Barcellini, Bruno Fattizzo & Agostino Cortelezzi. (2018) Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly. European Journal of Internal Medicine 58, pages 77-83.
Crossref
Claire L. Harris, Richard B. Pouw, David Kavanagh, Ruyue Sun & Daniel Ricklin. (2018) Developments in anti-complement therapy; from disease to clinical trial. Molecular Immunology 102, pages 89-119.
Crossref
Wilma Barcellini, Anna Zaninoni, Bruno Fattizzo, Juri Alessandro Giannotta, Monia Lunghi, Antonella Ferrari, Anna Paola Leporace, Nilla Maschio, Laura Scaramucci, Silvia Cantoni, Federico Chiurazzi, Dario Consonni, Giuseppe Rossi, Paolo De Fabritiis, Gianluca Gaidano, Alberto Zanella & Agostino Cortelezzi. (2018) Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. American Journal of Hematology 93:9, pages E243-E246.
Crossref
Giuseppe RossiDoriana GramegnaFrancesca PaoloniBruno FattizzoFrancesca BindaMariella D’AddaMirko FarinaElisa LucchiniFrancesca Romana MauroFlavia Salvi, Monia Marchetti, Paola FaziFrancesco ZajaWilma Barcellini. (2018) Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study. Blood 132:5, pages 547-550.
Crossref
Sigbjørn Berentsen. (2018) Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease. Seminars in Hematology 55:3, pages 141-149.
Crossref
Delia Tulbă, Marius Balea & Cristian Băicuş. (2018) Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report. Romanian Journal of Internal Medicine 56:1, pages 67-70.
Crossref
Megan MullinsXiaohui JiangLauren C. BylsmaJon P. FryzekHeidi ReichertEvan C. Chen, Shivaani Kummar & Adam Rosenthal. (2017) Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization. Blood Advances 1:13, pages 839-848.
Crossref
Howard A. Liebman & Ilene C. Weitz. (2017) Autoimmune Hemolytic Anemia. Medical Clinics of North America 101:2, pages 351-359.
Crossref
Valentina Giudice, Rosa Rosamilio, Idalucia Ferrara, Elisa Seneca, Bianca Serio & Carmine Selleri. (2016) Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. Open Medicine 11:1, pages 374-380.
Crossref
Sarah Green, Erica Partridge, Edore Idedevbo & Anton Borg. (2016) Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil. Case Reports in Hematology 2016, pages 1-4.
Crossref
W. Barcellini & B. Fattizzo. (2015) Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia. Disease Markers 2015, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.